Effects of anti-sclerostin antibody and running on bone remodeling and strength.

Toumi, H; Benaitreau, D; Pallu, S; Mazor, M; Hambli, R; Ominsky, M; Lespessailles, E.

Afiliação

Toumi H; Service de Rhumatologie, Centre hospitalier régional d'Orléans, 1 rue Porte Madeleine, 45032 Orléans, France; University of Orléans, I3MTO Laboratory, EA 4708, Hospital of Orleans, 1 rue Porte Madeleine, F-45032 Orléans, France.
Benaitreau D; University of Orléans, I3MTO Laboratory, EA 4708, Hospital of Orleans, 1 rue Porte Madeleine, F-45032 Orléans, France.
Pallu S; University of Orléans, I3MTO Laboratory, EA 4708, Hospital of Orleans, 1 rue Porte Madeleine, F-45032 Orléans, France.
Mazor M; University of Orléans, I3MTO Laboratory, EA 4708, Hospital of Orleans, 1 rue Porte Madeleine, F-45032 Orléans, France.
Hambli R; Prisme Institute, MMH, 8, Rue Leonard de Vinci, 45072 Orleans Cedex 2, France.
Ominsky M; Metabolic Disorders, Amgen Inc., One Amgen Center Dr., Thousand Oaks, 91320 CA, USA.
Lespessailles E; Service de Rhumatologie, Centre hospitalier régional d'Orléans, 1 rue Porte Madeleine, 45032 Orléans, France; University of Orléans, I3MTO Laboratory, EA 4708, Hospital of Orleans, 1 rue Porte Madeleine, F-45032 Orléans, France.

Bone Rep ; 2: 52-58, 2015 Jun.

Article em En | MEDLINE | ID: mdl-28377954